8/2/2021 8:42:36 AM
Allogene Therapeutics Appoints Elizabeth Barrett And Vicki Sato To Board
6/21/2021 7:05:36 AM
Allogene Overland Biopharm Appoints Shuyuan Yao As CEO
12/15/2020 6:09:33 AM
Allogene Therapeutics And Overland Form JV To Develop And Commercialize AlloCAR T Cell Therapies
7/20/2020 8:33:00 AM
Notch Therapeutics Appoints David Main As President And CEO
6/1/2020 10:09:14 PM
Allogene Therapeutics Prices Public Offering Of 11.70 Mln Shares At $47.00/shr
6/1/2020 6:42:10 AM
Allogene Therapeutics Announces Commencement Of Public Offering Of $450.0 Mln Of Common Stock
3/24/2020 7:08:35 AM
MaxCyte, Allogene Therapeutics Sign Clinical And Commercial License Deal To Enable Advancement Of AlloCAR T Therapies